ANGPT2 and cerebral cavernous malformation: However, whole-mount and H&E staining demonstrated that the antibody abrogated CCM lesion formation in the 2-month-old Pdcd10BECKO mice (Supplementary Fig. 9h-j), suggesting a long-term effect of Angpt2-neutralizing antibody on CCM lesion progression.